Journal of Pharmaceutical and Biomedical Analysis 1995-08-01

A competitive enzyme linked immunosorbent assay for the determination of N-acetyltransferase (NAT2) phenotypes.

P Wong, B Leyland-Jones, I W Wainer

Index: J. Pharm. Biomed. Anal. 13(9) , 1079-86, (1995)

Full Text: HTML

Abstract

The ratio of 5-acetylamino-6-amino-3-methyluracil (AAMU) to 1-methylxanthine (1X) in urine samples after caffeine ingestion can be used to indicate human N-acetyltransferase (NAT2) phenotypes. In previous studies, this ratio has been determined by LC or capillary electrophoresis. The possibility that this ratio could be determined by competitive antigen enzyme linked immunosorbent assays (ELISAs) has been investigated. Polyclonal antibodies were raised in rabbits against synthetic derivatives of AAMU and 1X, and competitive antigen ELISAs were developed after isolation of the IgGs by ion-exchange chromatography. The competitive antigen ELISA correctly identified previously determined NAT2 phenotypes and gave the expected distribution of slow and fast N-acetylators within a group of 48 individuals.

Related Compounds

  • N-(6-amino-3-methy...

Related Articles:

Caffeine as a metabolic probe: validation of its use for acetylator phenotyping.

1991-06-01

[Clin. Pharmacol. Ther. 49(6) , 648-57, (1991)]

An alternative test for acetylator phenotyping with caffeine.

1987-11-01

[Clin. Pharmacol. Ther. 42(5) , 509-13, (1987)]

Extractionless method for the simultaneous high-performance liquid chromatographic determination of urinary caffeine metabolites for N-acetyltransferase 2, cytochrome P450 1A2 and xanthine oxidase activity assessment.

2001-05-05

[J. Chromatogr. B. Biomed. Sci. Appl. 755(1-2) , 73-84, (2001)]

Human N-acetylation genotype determination with urinary caffeine metabolites.

1990-04-01

[Clin. Pharmacol. Ther. 47(4) , 470-7, (1990)]

Phenotyping of N-acetyltransferase type 2 and xanthine oxidase with caffeine: when should urine samples be collected?

2009-04-01

[Eur. J. Clin. Pharmacol. 65(4) , 411-7, (2009)]

More Articles...